欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/0141/001
药品名称Furosemide Fresenius Kabi 20mg/2ml solution for injection
活性成分
    • furosemide 20.0 mg/2ml
剂型Solution for injection
上市许可持有人Fresenius Kabi Pharma Portugal Lda, Avenida do Forte, No.3 - Edificio Suécia III, Piso 2 2790-073 Carnaxide Portugal
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Belgium (BE)
    • Netherlands (NL)
      Furosemide Fresenius Kabi 20 mg/2 ml, oplossing voor injectie
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Spain (ES)
    • Finland (FI)
    • Poland (PL)
    • Czechia (CZ)
    • Slovakia (SK)
      Furosemid Kabi 20 mg/2 ml
许可日期2007/03/14
最近更新日期2024/03/12
药物ATC编码
    • C03CA01 furosemide
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase